Rznomics (476830 KS)

Health Care • South Korea

Rznomics Inc. provides gene therapies development services. The Company develops hepatocellular carcinoma gene therapy, target-specific RNA replacement enzyme, genetic diseases gene therapy, and other related gene therapies. Rznomics conducts businesses at home and abroad.

Refresh

No publications yet

No AI primers are available right now. Create one using Smartkarma AI.

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00